A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Long term use of bronchodilators in CF is beneficial to the improvement of pulmonary function
and symptoms. This study is investigating the long-term benefit of administration of the drug
Salmeterol, a bronchodilator. Salmeterol will be compared to albuterol or placebo. The
medication will be inhaled twice a day for 6 months.